Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTR
2301
DELISTED
Frontier Communications Corp.
FTR
| $906K | ﹤0.01% |
17,864
-9,811
| -35% | -$538K |
|
|
ARAV
2302
DELISTED
Aravive, Inc. Common Stock
ARAV
| $905K | ﹤0.01% |
10,123
+2,421
| +31% | +$183K |
|
|
POT
2303
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $905K | ﹤0.01% |
+50,000
| New | +$866K |
|
|
VNET
2304
VNET Group
VNET
$1.88B
| $902K | ﹤0.01% |
128,631
-12,872
| -9% | -$96.2K |
|
2305
Red Rock Resorts
RRR
$3.53B
| $899K | ﹤0.01% |
38,786
-42,597
| -52% | -$969K |
|
|
BKS
2306
DELISTED
Barnes & Noble
BKS
| $899K | ﹤0.01% |
80,649
-371,037
| -82% | -$4.26M |
|
2307
Rush Enterprises Class B
RUSHB
$8.31B
| $897K | ﹤0.01% |
+65,365
| New | +$774K |
|
2308
Nomad Foods
NOMD
$1.7B
| $891K | ﹤0.01% |
93,068
-113,184
| -55% | -$1.24M |
|
|
MBTF
2309
DELISTED
MBT Financial Corporation
MBTF
| $891K | ﹤0.01% |
78,463
+55,633
| +244% | +$542K |
|
2310
Argan
AGX
$6.38B
| $888K | ﹤0.01% |
39,975
+27,574
| +222% | +$1.72M |
|
|
OMN
2311
DELISTED
OMNOVA Solutions Inc.
OMN
| $886K | ﹤0.01% |
88,649
-51,412
| -37% | -$454K |
|
|
HOLI
2312
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $883K | ﹤0.01% |
48,217
+29,985
| +164% | +$594K |
|
2313
Limoneira
LMNR
$245M
| $882K | ﹤0.01% |
+40,993
| New | +$794K |
|
|
GLOP
2314
DELISTED
GASLOG PARTNERS LP
GLOP
| $881K | ﹤0.01% |
42,873
+24,838
| +138% | +$511K |
|
|
ERN
2315
DELISTED
Erin Energy Corp
ERN
| $881K | ﹤0.01% |
+288,861
| New | +$674K |
|
|
AM
2316
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $880K | ﹤0.01% |
+28,500
| New | +$819K |
|
|
IMDZ
2317
DELISTED
Immune Design Corp.
IMDZ
| $877K | ﹤0.01% |
159,490
+136,451
| +592% | +$964K |
|
2318
Valvoline
VVV
$4.18B
| $876K | ﹤0.01% |
40,730
-1,164,086
| -97% | -$24.7M |
|
2319
Tactile Systems Technology
TCMD
$533M
| $875K | ﹤0.01% |
53,310
+38,010
| +248% | +$659K |
|
|
PETX
2320
DELISTED
Aratana Therapeutics, Inc.
PETX
| $874K | ﹤0.01% |
121,761
-147,823
| -55% | -$1.2M |
|
|
BT
2321
DELISTED
BT Group plc (ADR)
BT
| $873K | ﹤0.01% |
+37,911
| New | +$876K |
|
|
ONDK
2322
DELISTED
On Deck Capital, Inc.
ONDK
| $872K | ﹤0.01% |
188,268
+171,468
| +1,021% | +$801K |
|
|
NGD
2323
DELISTED
New Gold Inc
NGD
| $871K | ﹤0.01% |
248,837
+47,666
| +24% | +$181K |
|
2324
CALL
O-I Glass
OI
$1.14B
| $871K | ﹤0.01% |
50,000
-250,000
| -83% | -$4.54M |
|
|
GNCMA
2325
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $870K | ﹤0.01% |
+44,722
| New | +$739K |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.